Topiramate is a new anticonvulsant with proven efficacy in migraine and other conditions, which reportedly confers weight loss in patients receiving doses up to 300 mg/day. Objective: The aim of ...

Drugs currently used for treating chronic tension-type headache only reduce headache frequency by about a third and are associated with side effects. Topiramate, an antiepileptic drug with ...

This was an open-label, uncontrolled study designed to observe the response of patients prescribed topiramate for migraine headache at a tertiary center. In addition, the patients were included in ...

Novartis’ injectable migraine prevention antibody Aimovig has been shown to be more effective than topiramate – a go-to oral therapy for people with chronic migraine – in a head-to-head trial.

Topiramate is a generic drug doctors prescribe for epilepsy and migraine in certain situations. How and when you take topiramate depends on what condition you’re taking the drug to treat.

Topamax (topiramate) is a brand-name prescription drug used to prevent migraine attacks and treat epilepsy in certain people. Long-term side effects with Topamax are not common but can occur in ...

Topamax (topiramate) is an anticonvulsant or a drug used to treat seizures. It is also approved to prevent migraine headaches ...

Get detailed information on Topiramate, including pronunciation ... prescribed for the treatment of seizures and prevents migraine headaches, either alone or with other medications.

In a clinical practice guideline (CPG) issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and published online Oct. 29 in the Anna ...

Topamax (topiramate) is a brand-name drug that a doctor or healthcare professional may prescribe off-label for weight loss. The drug is not approved for this use, but it has been shown to help ...

The anticonvulsant topiramate causes dose-dependent weight loss in humans and in animal models of diabetes. Toplak and colleagues, therefore, investigated the efficacy and safety of topiramate as ...